Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emilse Roncancio-Diaz"'
Autor:
Filipa Landeiro, Seher Mughal, Katie Walsh, Elsbeth Nye, Jasmine Morton, Harriet Williams, Isaac Ghinai, Yovanna Castro, José Leal, Nia Roberts, Helena Wace, Ron Handels, Pascal Lecomte, Anders Gustavsson, Emilse Roncancio-Diaz, Mark Belger, Gurleen S. Jhuti, Jacoline C. Bouvy, Michele H. Potashman, Antje Tockhorn-Heidenreich, Alastair M. Gray, on behalf of the ROADMAP consortium
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020)
Abstract Background Obtaining reliable estimates of the health-related quality of life (HR-QoL) of people with predementia Alzheimer’s disease [AD] (preclinical or prodromal AD), mild cognitive impairment (MCI) and dementia is essential for economi
Externí odkaz:
https://doaj.org/article/57822cd3575e47489f659ffac536b1ce
Autor:
Filipa Landeiro, Jasmine Morton, Anders Gustavsson, Michele Potashman, Pascal Lecomte, Mark Belger, Robin Thompson, Emilse Roncancio‐Diaz, Gurleen Jhuti, Christopher Butler, Linus Jönsson, Ron Handels, Alastair M. Gray, the ROADMAP study
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly c
Externí odkaz:
https://doaj.org/article/8b096dbb28a34191a377db2b6db52ed4
Autor:
Claire Tochel, Michael Smith, Helen Baldwin, Anders Gustavsson, Amanda Ly, Christin Bexelius, Mia Nelson, Christophe Bintener, Enrico Fantoni, Josep Garre‐Olmo, Olin Janssen, Christoph Jindra, Isabella F. Jørgensen, Alex McKeown, Buket Öztürk, Anna Ponjoan, Michele H. Potashman, Catherine Reed, Emilse Roncancio‐Diaz, Stephanie Vos, Cathie Sudlow, the ROADMAP consortium
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 231-247 (2019)
Abstract Introduction Clinical trials involving patients with Alzheimer's disease (AD) continue to try to identify disease‐modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outc
Externí odkaz:
https://doaj.org/article/57e677c42d614929bedcb9d26f020449
Autor:
Christophe Bintener, Michael Sharwood Smith, Michele Potashman, Amanda Ly, Alex McKeown, Christoph Jindra, Anders Gustavsson, Emilse Roncancio-Diaz, Cathie Sudlow, Olin Janssen, Anna Ponjoan, Claire Tochel, Stephanie J.B. Vos, Isabella Friis Jørgensen, Buket Öztürk, Catherine Reed, Josep Garre-Olmo, Mia Nelson, Christin Bexelius, Helen Baldwin, Enrico R. Fantoni
Publikováno v:
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, I F, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, M H, Reed, C, Roncancio-Diaz, E, Vos, S & Sudlow, C 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's & Dementia, vol. 11, pp. 231-247 . https://doi.org/10.1016/j.dadm.2018.12.003
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jorgensen, I, McKeown, A, Ozturk, B, Ponjoan, A, Potashman, M, Reed, C, Roncancio-Diaz, E, Vos, S & Sudlow, C 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring . https://doi.org/10.1016/j.dadm.2018.12.003
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, I F, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, M H, Reed, C, Roncancio-Diaz, E, Vos, S, Sudlow, C & ROADMAP consortium 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 11, pp. 231-247 . https://doi.org/10.1016/j.dadm.2018.12.003
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11(1), 231-247. Elsevier BV
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 231-247 (2019)
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jorgensen, I, McKeown, A, Ozturk, B, Ponjoan, A, Potashman, M, Reed, C, Roncancio-Diaz, E, Vos, S & Sudlow, C 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring . https://doi.org/10.1016/j.dadm.2018.12.003
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, I F, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, M H, Reed, C, Roncancio-Diaz, E, Vos, S, Sudlow, C & ROADMAP consortium 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 11, pp. 231-247 . https://doi.org/10.1016/j.dadm.2018.12.003
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11(1), 231-247. Elsevier BV
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 231-247 (2019)
Introduction: Clinical trials involving patients with Alzheimer’s disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b9fc902e29a50872ed92ca7654b159
https://cris.maastrichtuniversity.nl/en/publications/0f468330-2ae5-4972-b0a4-e3b057ce4213
https://cris.maastrichtuniversity.nl/en/publications/0f468330-2ae5-4972-b0a4-e3b057ce4213
Autor:
Landeiro, Filipa, Mughal, Seher, Walsh, Katie, Nye, Elsbeth, Morton, Jasmine, Williams, Harriet, Ghinai, Isaac, Yovanna Castro, Leal, José, Roberts, Nia, Wace, Helena, Handels, Ron, Lecomte, Pascal, Gustavsson, Anders, Emilse Roncancio-Diaz, Belger, Mark, Gurleen S. Jhuti, Bouvy, Jacoline C., Potashman, Michele H., Tockhorn-Heidenreich, Antje, Gray, Alastair M.
Additional file 1. Landeiro HR QOL SLR appendices. Additional back-up information to support the main paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2774b025c3a01fcf5cb54d12147d5b91
Autor:
Nia Roberts, Jane Wolstenholme, Katie Walsh, Elsbeth Nye, Raphael Wittenberg, Pascal Lecomte, Seher Mughal, Helena Wace, Antje Tockhorn-Heidenreich, Isaac Ghinai, Emilse Roncancio-Diaz, Michele Potashman, Ron Handels, Alastair Gray, Filipa Landeiro
Publikováno v:
BMJ Open
IntroductionDementia is the fastest growing major cause of disability globally with a mounting social and financial impact for patients and their families but also to health and social care systems. This review aims to systematically synthesise evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ef7802c124b599dd220a7f8a575f86
http://eprints.lse.ac.uk/87738/
http://eprints.lse.ac.uk/87738/